欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	FR/H/0554/002
药品名称	BABIVEN NN2
活性成分	acetylcysteine 0.38 g/l alanine 1.64 g/l arginine 1.08 g/l aspartic acid 1.08 g/l calcium gluconate 3.44 g/l chromium(III)chloride hexahydrate 0.02 mg/l copper sulfate 1.04 mg/l glucose monohydrate 110.0 g/l glutamic acid 1.84 g/l glycine 0.56 g/l histidine 0.56 g/l isoleucine 0.8 g/l leucine 1.84 g/l lysine monohydrate 1.6 g/l magnesium lactate 0.39 g/l manganese(II)chloride 0.02 mg/l methionine 0.32 g/l phenylalanine 0.72 g/l Potassium Dihydrogen Phosphate 1.24 g/l potassium hydroxide 0.44 g/l potassium iodide 0.01 mg/l proline 1.44 g/l serine 1.0 g/l sodium fluoride 0.2 mg/l sodium chloride 1.16 g/l taurine 0.08 g/l threonine 0.92 g/l tryptophan 0.36 g/l tyrosine 0.12 g/l valine 0.92 g/l zinc acetate, basic 7.72 mg/l
剂型	Solution for infusion
上市许可持有人	Fresenius Kabi France
参考成员国 - 产品名称	France (FR)
互认成员国 - 产品名称	Belgium (BE) Kidiamix Netherlands (NL) Austria (AT) Pediaven Glucose 10% Infusionslösung Portugal (PT) Italy (IT) Poland (PL) Latvia (LV) Pediaven Start-Up šķīdums infūzijām Lithuania (LT) Pediaven NN2 infuzinis tirpalas Estonia (EE) PEDIAVEN NN2 Hungary (HU)
许可日期	2014/05/05
最近更新日期	2020/03/09
药物ATC编码	B05BA10 combinations
申请类型	TypeLevel1：Known Active Substance TypeLevel2：Initial Application TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载
市场状态	Positive